Thalidomide in combination with interferon in the induction therapy for relapsed refractory T-cell lymphoma:two cases report and literature review / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 595-597, 2015.
Article
en Zh
| WPRIM
| ID: wpr-480830
Biblioteca responsable:
WPRO
ABSTRACT
Objective To observe the effectiveness and side-effect of two cases of relapsed and refractory T-cell lymphoma (TCL) treated with thalidomide and interferon.Methods Two cases of relapsed and refractory TCL was treated with thalidomide and interferon, the efficacy and side-effect were observed, and the relevant literature was reviewed.Results The patients achieved partially remission after being treated with thalidomide and interferon.Conclusion Thalidomide in combination with interferon can be used as a second line therapy for relapsed and refractory TCL.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2015
Tipo del documento:
Article